Mayne Pharma Group's total assets for Q2 2026 were AU$940.55M, a decrease of -7.30% from the previous quarter. MAYNF total liabilities were AU$587.84M for the fiscal quarter, a -8.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.